The Ensign Group, Inc. $ENSG Shares Sold by Royce & Associates LP

Royce & Associates LP reduced its position in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 34.7% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,863 shares of the company’s stock after selling 2,582 shares during the period. Royce & Associates LP’s holdings in The Ensign Group were worth $840,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in The Ensign Group by 9.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 161,946 shares of the company’s stock worth $20,956,000 after purchasing an additional 14,590 shares during the period. Geneos Wealth Management Inc. lifted its holdings in shares of The Ensign Group by 150.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 383 shares of the company’s stock valued at $50,000 after buying an additional 230 shares during the period. Hantz Financial Services Inc. boosted its stake in shares of The Ensign Group by 1,128.6% in the second quarter. Hantz Financial Services Inc. now owns 258 shares of the company’s stock valued at $40,000 after buying an additional 237 shares in the last quarter. Assetmark Inc. grew its holdings in The Ensign Group by 296.2% during the second quarter. Assetmark Inc. now owns 412 shares of the company’s stock worth $64,000 after acquiring an additional 308 shares during the period. Finally, State of Michigan Retirement System grew its holdings in The Ensign Group by 0.7% during the second quarter. State of Michigan Retirement System now owns 13,700 shares of the company’s stock worth $2,113,000 after acquiring an additional 100 shares during the period. Institutional investors and hedge funds own 96.12% of the company’s stock.

The Ensign Group Price Performance

Shares of NASDAQ:ENSG opened at $207.23 on Friday. The company has a market cap of $12.00 billion, a P/E ratio of 35.48, a P/E/G ratio of 2.03 and a beta of 0.83. The business has a fifty day simple moving average of $190.75 and a 200-day simple moving average of $181.50. The Ensign Group, Inc. has a 52 week low of $118.73 and a 52 week high of $218.00. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.06.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.75 by $0.07. The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The firm’s revenue for the quarter was up 20.2% compared to the same quarter last year. During the same period in the prior year, the business posted $1.49 earnings per share. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. Equities research analysts forecast that The Ensign Group, Inc. will post 5.59 EPS for the current year.

The Ensign Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Saturday, January 31st. Investors of record on Wednesday, December 31st were given a $0.065 dividend. This is a boost from The Ensign Group’s previous quarterly dividend of $0.06. This represents a $0.26 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend was Wednesday, December 31st. The Ensign Group’s dividend payout ratio is 4.45%.

Analyst Ratings Changes

A number of research firms have commented on ENSG. UBS Group set a $230.00 target price on The Ensign Group and gave the company a “buy” rating in a report on Friday, February 6th. Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Truist Financial set a $215.00 target price on shares of The Ensign Group and gave the stock a “hold” rating in a research report on Friday, February 6th. Zacks Research upgraded shares of The Ensign Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 26th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a report on Thursday, January 22nd. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $204.60.

Insiders Place Their Bets

In other The Ensign Group news, Director Daren Shaw sold 1,000 shares of The Ensign Group stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $213.43, for a total value of $213,430.00. Following the transaction, the director owned 23,726 shares in the company, valued at $5,063,840.18. This trade represents a 4.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Suzanne D. Snapper sold 4,573 shares of The Ensign Group stock in a transaction on Friday, February 6th. The shares were sold at an average price of $196.11, for a total transaction of $896,811.03. Following the completion of the transaction, the chief financial officer owned 272,889 shares in the company, valued at approximately $53,516,261.79. This trade represents a 1.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 27,473 shares of company stock valued at $5,167,422. 3.90% of the stock is currently owned by corporate insiders.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.